Thursday 20 Sep 2018 @ 09:15
National Institute for Health and Clinical Excellence (NICE)
National Institute for Health and Clinical Excellence (NICE)
Printable version |
NICE encourages further discussions on Kymriah for adult lymphoma
CAR-T is too expensive to recommend as a treatment for adults with lymphoma, NICE says in draft guidance yesterday (19 September).
Channel website: https://www.nice.org.uk/
Original article link: https://www.nice.org.uk/news/article/nice-encourages-further-discussions-on-kymriah-for-adult-lymphoma
Original article link: https://www.nice.org.uk/news/article/nice-encourages-further-discussions-on-kymriah-for-adult-lymphoma
Share this article